Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Non-Current Deferred Tax Liability: 2019-2021

  • Legend Biotech's Non-Current Deferred Tax Liability fell 35.05% to $22.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $22.8 million, marking a year-over-year decrease of 35.05%. This contributed to the annual value of $22.8 million for FY2021, which is 35.05% down from last year.
  • As of Q4 2021, Legend Biotech's Non-Current Deferred Tax Liability stood at $22.8 million, which was down 35.05% from $35.0 million recorded in Q4 2020.
  • In the past 5 years, Legend Biotech's Non-Current Deferred Tax Liability ranged from a high of $47.7 million in Q4 2019 and a low of $22.8 million during Q4 2021.
  • In the last 3 years, Legend Biotech's Non-Current Deferred Tax Liability had a median value of $35.0 million in 2020 and averaged $35.2 million.
  • Data for Legend Biotech's Non-Current Deferred Tax Liability shows a maximum YoY plummeted of 35.05% (in 2021) over the last 5 years.
  • Quarterly analysis of 3 years shows Legend Biotech's Non-Current Deferred Tax Liability stood at $47.7 million in 2019, then declined by 26.54% to $35.0 million in 2020, then tumbled by 35.05% to $22.8 million in 2021.
  • Its last three reported values are $22.8 million in Q4 2021, $35.0 million for Q4 2020, and $47.7 million during Q4 2019.